Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Novartis Pharmaceuticals UK Ltd., Trading as Geigy Pharmaceuticals, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Voltarol Suppositories 12.5mg, 25mg, 50mg and 100mg.
| Pharmaceutical Form |
|---|
|
Suppositories. |
The active substance is sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate (diclofenac sodium).
Each suppository contains 12.5mg, 25mg, 50mg and 100mg diclofenac sodium Ph.Eur.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
| List of Excipients |
|---|
|
Voltarol suppositories also contain suppository mass 5 (a waxy base composed of hard fat). |
The suppositories are white to yellowish, torpedo-shaped, with smooth or slightly rough surfaces and a slightly fatty odour, and are sealed in a composite foil made of polyvinylchloride (PVC) laminated with low-density polyethylene (LD-PE).
They come in packs of 10.
Novartis Pharmaceuticals UK Ltd., Trading as Geigy Pharmaceuticals, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
12.5mg: PL 00101/0472
25mg: PL 00101/0473
50mg: PL 00101/0474
100mg: PL 00101/0475
11 July 1997 / 29 July 2007
| Drug | Countries | |
|---|---|---|
| VOLTAROL | Estonia, Ireland, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
